- Home
- EBS vs HPF Comparison
EBS vs HPF Comparison
Compare EBS & HPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBS
- HPF
- Stock Information
- Founded
- EBS 1998
- HPF 2002
- Country
- EBS United States
- HPF United States
- Employees
- EBS N/A
- HPF N/A
- Industry
- EBS Biotechnology: Pharmaceutical Preparations
- HPF Finance Companies
- Sector
- EBS Health Care
- HPF Finance
- Exchange
- EBS Nasdaq
- HPF Nasdaq
- Market Cap
- EBS 393.9M
- HPF 325.2M
- IPO Year
- EBS 2006
- HPF N/A
- Fundamental
- Price
- EBS $6.38
- HPF $16.10
- Analyst Decision
- EBS Strong Buy
- HPF
- Analyst Count
- EBS 3
- HPF 0
- Target Price
- EBS $14.33
- HPF N/A
- AVG Volume (30 Days)
- EBS 1.1M
- HPF 35.3K
- Earning Date
- EBS 05-07-2025
- HPF 01-01-0001
- Dividend Yield
- EBS N/A
- HPF 8.96%
- EPS Growth
- EBS N/A
- HPF N/A
- EPS
- EBS N/A
- HPF N/A
- Revenue
- EBS $965,400,000.00
- HPF N/A
- Revenue This Year
- EBS N/A
- HPF N/A
- Revenue Next Year
- EBS $19.88
- HPF N/A
- P/E Ratio
- EBS N/A
- HPF N/A
- Revenue Growth
- EBS N/A
- HPF N/A
- 52 Week Low
- EBS $4.02
- HPF $12.99
- 52 Week High
- EBS $15.10
- HPF $16.80
- Technical
- Relative Strength Index (RSI)
- EBS 65.88
- HPF 55.52
- Support Level
- EBS $4.71
- HPF $15.75
- Resistance Level
- EBS $5.70
- HPF $16.13
- Average True Range (ATR)
- EBS 0.38
- HPF 0.21
- MACD
- EBS 0.13
- HPF 0.10
- Stochastic Oscillator
- EBS 85.77
- HPF 61.59
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
About HPF John Hancock Pfd Income Fund II Pfd Income Fund II
John Hancock Preferred Income Fund II is the United States based closed-end, diversified management investment company. Its primary objective is to provide a high level of current income consistent with preservation of capital. The fund's secondary investment objective is to provide growth of capital to the extent consistent with its primary investment objective. The fund's principal investment strategies include to invests a majority of its assets in preferred stocks and other preferred securities, including convertible preferred securities. Its portfolio composition consists of U.S preferred securities, common stocks, foreign preferred securities, corporate bonds, capital preferred securities and short-term investments.